Is it time to revisit the role of ultrasound in rheumatoid arthritis management?

M. A. D'Agostino, M. Boers, R. J. Wakefield, P. Emery, P. G. Conaghan

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

For over a decade, a large number of studies have highlighted the benefits of ultrasound (US) in the diagnosis and management of rheumatic diseases, especially rheumatoid arthritis (RA). However, its benefits in routine practice have been less studied and trials examining US as part of various clinical strategies are just emerging, with recent randomised trials examining the added value of US in tight-control paradigms. The conclusions of these trials have raised questions on the role of US in RA management. This Viewpoint analyses the recent studies, and discusses potential limitations in study designs as well as the methodological challenges of assessing the added value of an imaging technique.

LanguageEnglish
Pages7-8
Number of pages2
JournalAnnals of the Rheumatic Diseases
Volume76
Issue number1
DOIs
Publication statusPublished - 2017

Cite this

D'Agostino, M. A. ; Boers, M. ; Wakefield, R. J. ; Emery, P. ; Conaghan, P. G. / Is it time to revisit the role of ultrasound in rheumatoid arthritis management?. In: Annals of the Rheumatic Diseases. 2017 ; Vol. 76, No. 1. pp. 7-8.
@article{d8af661afd7a481f817d068222c7906b,
title = "Is it time to revisit the role of ultrasound in rheumatoid arthritis management?",
abstract = "For over a decade, a large number of studies have highlighted the benefits of ultrasound (US) in the diagnosis and management of rheumatic diseases, especially rheumatoid arthritis (RA). However, its benefits in routine practice have been less studied and trials examining US as part of various clinical strategies are just emerging, with recent randomised trials examining the added value of US in tight-control paradigms. The conclusions of these trials have raised questions on the role of US in RA management. This Viewpoint analyses the recent studies, and discusses potential limitations in study designs as well as the methodological challenges of assessing the added value of an imaging technique.",
author = "D'Agostino, {M. A.} and M. Boers and Wakefield, {R. J.} and P. Emery and Conaghan, {P. G.}",
year = "2017",
doi = "10.1136/annrheumdis-2016-210453",
language = "English",
volume = "76",
pages = "7--8",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "1",

}

Is it time to revisit the role of ultrasound in rheumatoid arthritis management? / D'Agostino, M. A.; Boers, M.; Wakefield, R. J.; Emery, P.; Conaghan, P. G.

In: Annals of the Rheumatic Diseases, Vol. 76, No. 1, 2017, p. 7-8.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Is it time to revisit the role of ultrasound in rheumatoid arthritis management?

AU - D'Agostino, M. A.

AU - Boers, M.

AU - Wakefield, R. J.

AU - Emery, P.

AU - Conaghan, P. G.

PY - 2017

Y1 - 2017

N2 - For over a decade, a large number of studies have highlighted the benefits of ultrasound (US) in the diagnosis and management of rheumatic diseases, especially rheumatoid arthritis (RA). However, its benefits in routine practice have been less studied and trials examining US as part of various clinical strategies are just emerging, with recent randomised trials examining the added value of US in tight-control paradigms. The conclusions of these trials have raised questions on the role of US in RA management. This Viewpoint analyses the recent studies, and discusses potential limitations in study designs as well as the methodological challenges of assessing the added value of an imaging technique.

AB - For over a decade, a large number of studies have highlighted the benefits of ultrasound (US) in the diagnosis and management of rheumatic diseases, especially rheumatoid arthritis (RA). However, its benefits in routine practice have been less studied and trials examining US as part of various clinical strategies are just emerging, with recent randomised trials examining the added value of US in tight-control paradigms. The conclusions of these trials have raised questions on the role of US in RA management. This Viewpoint analyses the recent studies, and discusses potential limitations in study designs as well as the methodological challenges of assessing the added value of an imaging technique.

UR - http://www.scopus.com/inward/record.url?scp=84995452432&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2016-210453

DO - 10.1136/annrheumdis-2016-210453

M3 - Review article

VL - 76

SP - 7

EP - 8

JO - Annals of the Rheumatic Diseases

T2 - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 1

ER -